| Primary |
| Computerised Tomogram |
32.2% |
| Percutaneous Coronary Intervention |
16.1% |
| Premedication |
6.3% |
| Therapeutic Embolisation |
5.7% |
| Arteriogram Coronary |
5.4% |
| Catheterisation Cardiac |
5.3% |
| Arthrogram |
4.0% |
| X-ray |
3.7% |
| Fluid Replacement |
3.5% |
| Angiogram |
3.3% |
| Computerised Tomogram Abdomen |
3.3% |
| Computerised Tomogram Thorax |
2.1% |
| Prophylaxis |
1.9% |
| Hypertension |
1.8% |
| Urogram |
1.4% |
| Prophylaxis Against Dehydration |
1.0% |
| Computerised Tomogram Head |
0.8% |
| Diabetes Mellitus |
0.8% |
| Anaesthesia |
0.7% |
| Hepatic Neoplasm Malignant |
0.6% |
|
| Nephropathy Toxic |
34.4% |
| Urticaria |
15.3% |
| Anaphylactic Shock |
5.4% |
| Rash |
4.8% |
| Throat Irritation |
4.6% |
| Throat Tightness |
4.2% |
| Wrong Technique In Drug Usage Process |
3.7% |
| Anaphylactic Reaction |
3.2% |
| Dyspnoea |
2.8% |
| Hypersensitivity |
2.8% |
| Vomiting |
2.6% |
| Pruritus |
2.5% |
| Nephropathy |
2.3% |
| Shock |
2.3% |
| Sneezing |
1.8% |
| Wheezing |
1.8% |
| Rash Generalised |
1.7% |
| Swelling Face |
1.4% |
| Cardio-respiratory Arrest |
1.2% |
| Unresponsive To Stimuli |
1.2% |
|
| Secondary |
| Arthrogram |
25.1% |
| X-ray Limb |
20.3% |
| Joint Injury |
14.5% |
| X-ray |
7.5% |
| Therapeutic Embolisation |
5.8% |
| Arthroscopy |
5.0% |
| Computerised Tomogram |
3.1% |
| Prophylaxis |
2.9% |
| Angiogram |
1.9% |
| Hepatic Neoplasm Malignant |
1.9% |
| Premedication |
1.7% |
| Arteriogram Coronary |
1.4% |
| Influenza |
1.4% |
| Percutaneous Coronary Intervention |
1.4% |
| Fluid Replacement |
1.2% |
| Pancreatic Carcinoma Metastatic |
1.2% |
| Analgesia |
1.0% |
| Urogram |
1.0% |
| Computerised Tomogram Thorax |
0.8% |
| Pain |
0.8% |
|
| Septic Arthritis Staphylococcal |
39.4% |
| Nephropathy Toxic |
6.7% |
| Injury |
5.8% |
| No Adverse Event |
5.8% |
| Pain |
5.8% |
| Throat Tightness |
4.8% |
| Anxiety |
3.8% |
| Death |
2.9% |
| Purulent Discharge |
2.9% |
| Scintillating Scotoma |
2.9% |
| Unresponsive To Stimuli |
2.9% |
| Wrong Technique In Drug Usage Process |
2.9% |
| Acute Generalised Exanthematous Pustulosis |
1.9% |
| Hypothyroidism |
1.9% |
| Joint Effusion |
1.9% |
| Procedural Hypotension |
1.9% |
| Tubulointerstitial Nephritis |
1.9% |
| Visual Impairment |
1.9% |
| Abnormal Sensation In Eye |
1.0% |
| Accidental Exposure |
1.0% |
|
| Concomitant |
| Nuclear Magnetic Resonance Imaging |
19.1% |
| Product Used For Unknown Indication |
17.5% |
| Arteriogram Coronary |
10.2% |
| Nuclear Magnetic Resonance Imaging Brain |
7.3% |
| Coronary Artery Bypass |
6.3% |
| Catheterisation Cardiac |
6.1% |
| Hyperphosphataemia |
4.5% |
| Peripheral Arterial Occlusive Disease |
4.5% |
| Anaemia |
3.5% |
| Angiogram |
2.8% |
| Nasopharyngitis |
2.6% |
| Arteriogram |
2.2% |
| Computerised Tomogram Abdomen |
2.2% |
| Brain Neoplasm |
2.0% |
| Cardiac Ablation |
2.0% |
| Aortic Valve Replacement |
1.6% |
| Temporal Arteritis |
1.6% |
| Acute Myeloid Leukaemia |
1.4% |
| Echocardiogram |
1.2% |
| Phlebectomy |
1.2% |
|
| Skin Ulcer |
20.2% |
| Pain |
10.7% |
| Anhedonia |
9.5% |
| Skin Plaque |
7.1% |
| Arthropathy |
6.0% |
| Injury |
6.0% |
| Emotional Distress |
4.8% |
| Renal Failure |
4.8% |
| Stress |
4.8% |
| Tubulointerstitial Nephritis |
4.8% |
| Depression |
3.6% |
| Unevaluable Event |
3.6% |
| Fear |
2.4% |
| Joint Stiffness |
2.4% |
| Skin Induration |
2.4% |
| Ventricular Extrasystoles |
2.4% |
| Coagulopathy |
1.2% |
| Dry Skin |
1.2% |
| Fear Of Death |
1.2% |
| Interstitial Lung Disease |
1.2% |
|
